First Wave BioPharma’s Acquisition of ImmunogenX

Lowenstein represented First Wave BioPharma, Inc. in the transaction.First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now